发明名称 Effective anticancer drugs against gefitinib-resistant human lung cancer cells comprising the daphnane diterpenoid compound
摘要 The present invention relates to an anticancer drug useful for drug resistance cancer cells and more specifically, to a composition which provides excellent destructive effect against cancer cells showing resistance to conventional anticancer drugs containing a compound separated from a Daphne genkwa extract. Especially, the composition of the present invention enables a user to overcome the anticancer drug resistance in cells which is resistant to a Gefitinib anticancer drug, and an epithelial growth factor receptor (EGFR) inhibitor. The composition has an anticancer effect against regular cancer cells and cells with the anticancer drug resistance, and is capable of being used as a pharmaceutically useful anticancer drug. [Reference numerals] (AA) Yuanhuadine (nM); (BB,FF) Control group; (CC,GG) 24 hours; (DD,HH) 48 hours; (EE) Gefitinib (nM)
申请公布号 KR101388635(B1) 申请公布日期 2014.04.25
申请号 KR20120081011 申请日期 2012.07.25
申请人 发明人
分类号 A61K31/336;A61K31/36;A61P35/00 主分类号 A61K31/336
代理机构 代理人
主权项
地址